Checkpoint Therapeutics, Inc. (CKPT) DCF Valuation

Checkpoint Therapeutics, Inc. (CKPT) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Checkpoint Therapeutics, Inc. (CKPT) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to calculate the intrinsic value of Checkpoint Therapeutics, Inc.? Our (CKPT) DCF Calculator integrates real-world data with comprehensive customization features, allowing you to adjust forecasts and enhance your investment strategies.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 1.7 1.1 .3 .2 .1 .1 .0 .0 .0 .0
Revenue Growth, % 0 -37.41 -74.93 -28.36 -46.35 -46.76 -46.76 -46.76 -46.76 -46.76
EBITDA -24.9 -23.2 -56.7 -58.3 -52.1 -.1 .0 .0 .0 .0
EBITDA, % -1454.92 -2170.35 -21165.3 -30381.77 -50629.13 -100 -100 -100 -100 -100
Depreciation .2 .2 .2 4.5 .0 .0 .0 .0 .0 .0
Depreciation, % 10.06 19.3 88.27 2318.23 0 43.53 43.53 43.53 43.53 43.53
EBIT -25.0 -23.4 -57.0 -62.8 -52.1 -.1 .0 .0 .0 .0
EBIT, % -1464.98 -2189.64 -21253.57 -32700 -50629.13 -100 -100 -100 -100 -100
Total Cash 26.1 40.8 54.7 12.1 4.9 .1 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .1 .0
Account Receivables, % 1.52 1.87 6.34 38.02 0
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0.000058548009 0.00009354537 0 0.000520833333 0 0.000134585342 0.000134585342 0.000134585342 0.000134585342 0.000134585342
Accounts Payable 3.1 3.4 16.1 11.5 6.6 .1 .0 .0 .0 .0
Accounts Payable, % 180.27 321.61 6022.01 6007.81 6378.64 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 0 0 0 0 0 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -24.9 -23.3 -56.9 -67.1 -52.1 -.1 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -21.7 -22.7 -44.0 -67.3 -57.0 -6.6 .0 .0 .0 .0
WACC, % 10.28 10.28 10.28 10.28 10.28 10.28 10.28 10.28 10.28 10.28
PV UFCF
SUM PV UFCF -6.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -6
Net Debt -5
Equity Value -1
Diluted Shares Outstanding, MM 19
Equity Value Per Share -0.06

What You Will Get

  • Comprehensive CKPT Financials: Access historical and projected data for precise valuation.
  • Customizable Parameters: Adjust discount rates, tax implications, revenue forecasts, and investment levels.
  • Real-Time Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Modeling: Explore various scenarios to assess Checkpoint Therapeutics' future potential.
  • User-Friendly Interface: Designed for industry experts while remaining approachable for newcomers.

Key Features

  • Comprehensive CKPT Financial Data: Gain access to precise pre-loaded historical financials and future forecasts.
  • Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic adjustments for DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Intuitive charts and summaries to help visualize your valuation outcomes.
  • Suitable for All Levels: A straightforward, easy-to-navigate layout designed for investors, CFOs, and consultants alike.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Checkpoint Therapeutics, Inc. (CKPT) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including Checkpoint Therapeutics, Inc.'s (CKPT) intrinsic value.
  • Step 5: Make well-informed investment choices or create reports based on the outputs.

Why Choose This Calculator for Checkpoint Therapeutics, Inc. (CKPT)?

  • Designed for Experts: A sophisticated tool utilized by biotech analysts, CFOs, and investment consultants.
  • Accurate Data: Checkpoint Therapeutics’ historical and projected financials are preloaded for precision.
  • Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance makes the process straightforward.

Who Should Use Checkpoint Therapeutics, Inc. (CKPT)?

  • Investors: Gain insights into innovative oncology solutions to inform your investment choices.
  • Healthcare Analysts: Streamline your research with comprehensive data on drug development and market potential.
  • Consultants: Effortlessly modify reports and presentations tailored to client needs in the biopharmaceutical sector.
  • Biotech Enthusiasts: Enhance your knowledge of cutting-edge cancer therapies through real-world case studies.
  • Educators and Students: Utilize as a valuable resource for learning about the biotechnology industry and drug commercialization.

What the Template Contains

  • Pre-Filled DCF Model: Checkpoint Therapeutics, Inc.'s (CKPT) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital specific to (CKPT).
  • Financial Ratios: Evaluate Checkpoint Therapeutics, Inc.'s (CKPT) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios for (CKPT).
  • Financial Statements: Annual and quarterly reports to support detailed analysis of Checkpoint Therapeutics, Inc. (CKPT).
  • Interactive Dashboard: Easily visualize key valuation metrics and results for (CKPT).

Es wurden keine passenden Produkte gefunden.